Related Experiment Video
Updated: Jun 15, 2026

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
Published on: February 23, 2024
Acute disseminated encephalomyelitis in children and adults: A focused review emphasizing new developments
1Wake Forest Baptist Health, Winston-Salem, NC, USA/Pediatric Multiple Sclerosis and Demyelinating Disorders Clinic, Wake Forest University, Winston-Salem, NC, USA.
Abstract:
Acute disseminated encephalomyelitis (ADEM) was originally described in the medical literature more than 200 years ago. However, consensus clinical diagnostic criteria are less than 15 years old. Accurate diagnostic testing for myelin oligodendrocyte glycoprotein (MOG) autoantibodies has only become clinically available in the last 3-5 years and has facilitated a rapidly evolving understanding of patients with recurrent demyelination following ADEM. The field is working to optimize treatment for these patients with hopes of prospective treatment studies in the not too distant future. New imaging data suggest that even monophasic demyelination may have long-term impacts that were previously unrecognized. Recent developments in the literature are described in order to guide practice for providers who treat both adults and children with monophasic and recurrent forms of ADEM with and without MOG antibodies.
Insights
Acute disseminated encephalomyelitis (ADEM) understanding evolves with new MOG antibody tests and imaging. This review guides clinicians on managing both monophasic and recurrent ADEM forms in adults and children.
Area of Science:
- Neurology
- Immunology
- Demyelinating Diseases
Background:
- Acute disseminated encephalomyelitis (ADEM) has a long history, but standardized diagnostic criteria are recent.
- Advances in diagnosing myelin oligodendrocyte glycoprotein (MOG) autoantibodies are transforming ADEM patient care.
- Emerging imaging data reveal potential long-term effects of even single-episode demyelination.
Purpose of the Study:
- To review recent literature on ADEM, focusing on evolving diagnostic and treatment paradigms.
- To provide guidance for clinicians managing both monophasic and recurrent ADEM.
- To address the growing understanding of ADEM associated with MOG antibodies.
Main Methods:
- Literature review of recent developments in ADEM research.
- Analysis of new diagnostic testing for MOG autoantibodies.
- Examination of updated imaging findings in demyelinating diseases.
Main Results:
- Clinical diagnostic criteria for ADEM have been established relatively recently.
- The availability of MOG autoantibody testing has significantly advanced the understanding of recurrent demyelination post-ADEM.
- New imaging insights suggest lasting impacts from monophasic demyelination.
Conclusions:
- The understanding of ADEM, particularly MOG antibody-associated forms, is rapidly evolving.
- Optimizing treatment for ADEM patients, including those with recurrent episodes, is an active area of research.
- This review aims to equip healthcare providers with current knowledge to manage diverse ADEM presentations.
Related Concept Videos
Rocky Mountain Spotted Fever
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Bacterial Meningitis II: Pathophysiology
Arboviral Encephalitis
Viral Meningitis

